Trials / Unknown
UnknownNCT03390400
Changes in Prostaglandin Levels in Laser Cataract Surgery (LCS) Subject to Laser Prevalence
Intraindividual Comparison of Prostaglandin E2 (PGE2) and Total-prostaglandin (PG) Following Femtosecond Laser-assisted Cataract Surgery Using a Low-energy, High-frequency Femtosecond Laser-Device in Regard to the Sequence of Anterior Capsulotomy and Lens Fragmentation
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Rupert Menapace · Academic / Other
- Sex
- All
- Age
- 40 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The investigational device is an approved femtosecond laser (FSL) device with an integrated imaging system to perform certain steps of the cataract procedure. The FSL will perform anterior capsulotomy and lens fragmentation in individuals suffering from age-related cataract with need of cataract surgery. Cataract surgery will be performed in subjects who have signed an informed consent form. Aqueous humor will be collected and screening will be performed for Total Prostaglandin and Prostaglandin E2 via en-bloc Enzyme-linked Immunosorbent Assay (ELISA)-Kit.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Femtosecondlaser-assisted | Femtosecondlaser-assisted Cataract Surgery will be performed bilateral on the same day with different laser settings. |
| PROCEDURE | Anterior Capsulotomy | Cataract Surgery |
| PROCEDURE | Lens Fragmentation | Cataract Surgery |
Timeline
- Start date
- 2017-05-29
- Primary completion
- 2018-01-02
- Completion
- 2018-03-14
- First posted
- 2018-01-04
- Last updated
- 2018-03-02
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT03390400. Inclusion in this directory is not an endorsement.